Monday, November 9, 2026

USD/EUR Bullish By 1% In The Last 10 Sessions

ViaNews Editorial Team

December 7, 2023

USD/EUR Bullish By 1% In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.18% for the last 10 sessions. At 08:07 EST on Thursday, 7 December, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 4.747% up from its 52-week low and 2.926% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.42%, a negative 0.03%, and a positive 0.31%, respectively.

USD/EUR's highest amplitude of average volatility was 0.42% (last week), 0.37% (last month), and 0.31% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd extends the decline below 1.0800, eurozone retail sales eyed. According to FXStreet on Wednesday, 6 December, "The EUR/USD pair remains under selling pressure below the 1.0800 psychological mark during the early Asian session on Wednesday. "
  • Eur/usd forex signal: euro meltdown has more room to run - 06 December 2023. According to DailyForex on Wednesday, 6 December, "The EUR/USD pair continued its downtrend and reached a low of 1.0780, its lowest point on November 14th. ", "The EUR/USD price plunged to a low of 1.0782, its lowest level since November 14th. "
  • According to FXStreet on Tuesday, 5 December, "If the EUR/USD continues to fall, it may come into contact with the 100-day SMA at 1.0774 as a first point of support. ", "If the EUR/USD continues to fall, it may encounter the initial point of support at the December low of 1.0804 (December 4,5). "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com